ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
WATERTOWN, Mass., Jan. 24, 2024 -- (Healthcare Sales & Marketing Network) -- ZWI Therapeutics, Inc. (ZWI), a biotechnology company focused on the development of protein therapeutics using proprietary new polymers, announces a Series A financing, the appoi... Biopharmaceuticals, Personnel, Venture Capital ZWI Therapeutics, polycarboxybetaine, gout, arthritis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Arthritis | Biotechnology | Gout | Marketing | Pharmaceuticals | Rheumatology | Venture Capital